Tag Archives: Breyanzi

CAR-T Cell Therapy Cancer Risks May Drop Off After Two Weeks of Therapy: Study

August 15, 2024 By: Tyler New

Earlier this year the FDA required six CAR-T drug manufacturers to add secondary cancer warnings to drug labeling, and recommended life-long cancer screenings for patients.
FDA Found 22 Cases of Cancer Linked to CAR-T Treatments: Report

January 26, 2024 By: Irvin Jackson

Genetic sequencing appears to confirm that some cases of cancer have a direct connection to CAR-T cell transgenes used in the medications, the FDA reports.
FDA Requires CAR-T Cancer Warnings Be Added For All Drugs in the Class

January 24, 2024 By: Irvin Jackson

Cancerous tumors can develop within weeks after receiving CAR-T drug infusions, some of which can be fatal, the FDA warns.

Lawsuit Alleges Suboxone Caused Dental Damage, Erosion and Tooth Decay (Posted 4 days ago)

Kentucky man has filed a lawsuit against Suboxone manufacturers, indicating the opioid treatment film strips were known for years to cause the kind of permanent tooth damage he suffered, long before warning labels were added by the drug manufacturer.

Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL (Posted 7 days ago)

Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

Judge Declines To Extend Bard PowerPort Lawsuit Deadlines Under Discovery Schedule (Posted 9 days ago)

As parties prepare for early Bard PowerPort lawsuit bellwether trials, the court rejected a request to extend discovery deadlines by two months.

Tag Archives: Breyanzi

CAR-T Cell Therapy Cancer Risks May Drop Off After Two Weeks of Therapy: Study

FDA Found 22 Cases of Cancer Linked to CAR-T Treatments: Report

FDA Requires CAR-T Cancer Warnings Be Added For All Drugs in the Class

More Top Stories

Review A Case